These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 36612828)
1. Lessons Learned from In-Person Conferences in the Times of COVID-19. Ehteshami M; Edgar CL; Delgado Ayala LY; Hagan M; Martin GS; Lam W; Schinazi RF Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612828 [TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial. Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM; Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478 [TBL] [Abstract][Full Text] [Related]
5. Pilot Investigation of SARS-CoV-2 Secondary Transmission in Kindergarten Through Grade 12 Schools Implementing Mitigation Strategies - St. Louis County and City of Springfield, Missouri, December 2020. Dawson P; Worrell MC; Malone S; Tinker SC; Fritz S; Maricque B; Junaidi S; Purnell G; Lai AM; Neidich JA; Lee JS; Orscheln RC; Charney R; Rebmann T; Mooney J; Yoon N; Petit M; Schmidt S; Grabeel J; Neill LA; Barrios LC; Vallabhaneni S; Williams RW; Goddard C; Newland JG; Neatherlin JC; Salzer JS; MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(12):449-455. PubMed ID: 33764961 [TBL] [Abstract][Full Text] [Related]
6. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses. Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236 [TBL] [Abstract][Full Text] [Related]
7. Physical distancing reduced the incidence of influenza and supports a favorable impact on SARS-CoV-2 spread in Mexico. Murillo-Zamora E; Guzmán-Esquivel J; Sánchez-Piña RA; Cedeño-Laurent G; Delgado-Enciso I; Mendoza-Cano O J Infect Dev Ctries; 2020 Sep; 14(9):953-956. PubMed ID: 33031079 [TBL] [Abstract][Full Text] [Related]
8. Impact of Wearing Masks, Hand Hygiene, and Social Distancing on Influenza, Enterovirus, and All-Cause Pneumonia During the Coronavirus Pandemic: Retrospective National Epidemiological Surveillance Study. Chiu NC; Chi H; Tai YL; Peng CC; Tseng CY; Chen CC; Tan BF; Lin CY J Med Internet Res; 2020 Aug; 22(8):e21257. PubMed ID: 32750008 [TBL] [Abstract][Full Text] [Related]
9. Impact of social distancing on early SARS-CoV-2 transmission in the United States. Sanchez JN; Reyes GA; Martínez-López B; Johnson CK Zoonoses Public Health; 2022 Sep; 69(6):746-756. PubMed ID: 35048530 [TBL] [Abstract][Full Text] [Related]
10. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial. Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289 [TBL] [Abstract][Full Text] [Related]
11. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus. Wu Z; Harrich D; Li Z; Hu D; Li D Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025 [TBL] [Abstract][Full Text] [Related]
12. The 27th Annual Midwest Microbial Pathogenesis Conference in the Age of COVID. Hammer ND; Waters CM J Bacteriol; 2022 Jun; 204(6):e0013622. PubMed ID: 35506693 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 Positivity Following an In-Person Surgical Society Meeting: A Cross-Sectional Survey Study. Silver CM; Joung RH; Visenio MR; Wang TS; Pawlik TM; Kim ES; Bilimoria KY J Surg Res; 2022 Oct; 278():267-270. PubMed ID: 35636202 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial. Bundgaard H; Bundgaard JS; Raaschou-Pedersen DET; von Buchwald C; Todsen T; Norsk JB; Pries-Heje MM; Vissing CR; Nielsen PB; Winsløw UC; Fogh K; Hasselbalch R; Kristensen JH; Ringgaard A; Porsborg Andersen M; Goecke NB; Trebbien R; Skovgaard K; Benfield T; Ullum H; Torp-Pedersen C; Iversen K Ann Intern Med; 2021 Mar; 174(3):335-343. PubMed ID: 33205991 [TBL] [Abstract][Full Text] [Related]
15. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
16. Analyzing the cost of medical student virtual conference registration by specialty during the COVID-19 pandemic. Veyg D; Gurevich R J Osteopath Med; 2021 Jul; 121(11):843-848. PubMed ID: 34237807 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461 [TBL] [Abstract][Full Text] [Related]
18. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the Respiratory Viral Panel PCR Test Results Before and After COVID-19 Pandemic]. Alp A; Taşçı O; Ergin A; Köseoğlu Eser Ö Mikrobiyol Bul; 2022 Oct; 56(4):667-681. PubMed ID: 36458713 [TBL] [Abstract][Full Text] [Related]
20. Interpersonal distancing preferences, touch behaviors to strangers, and country-level early dynamics of SARS-CoV-2 spread. Sorokowska A; Saluja S; Kafetsios K; Croy I Am Psychol; 2022 Jan; 77(1):124-134. PubMed ID: 34807637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]